Poh, H.M.; Chiou, Y.S.; Chong, Q.Y.; Chen, R.-M.; Rangappa, K.S.; Ma, L.; Zhu, T.; Kumar, A.P.; Pandey, V.; Basappa;
et al. Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma. Cancers 2019, 11, 1528.
https://doi.org/10.3390/cancers11101528
AMA Style
Poh HM, Chiou YS, Chong QY, Chen R-M, Rangappa KS, Ma L, Zhu T, Kumar AP, Pandey V, Basappa,
et al. Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma. Cancers. 2019; 11(10):1528.
https://doi.org/10.3390/cancers11101528
Chicago/Turabian Style
Poh, Han Ming, Yi Shiou Chiou, Qing Yun Chong, Ru-Mei Chen, Kanchugarakoppal S. Rangappa, Lan Ma, Tao Zhu, Alan Prem Kumar, Vijay Pandey, Basappa,
and et al. 2019. "Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma" Cancers 11, no. 10: 1528.
https://doi.org/10.3390/cancers11101528
APA Style
Poh, H. M., Chiou, Y. S., Chong, Q. Y., Chen, R. -M., Rangappa, K. S., Ma, L., Zhu, T., Kumar, A. P., Pandey, V., Basappa, Lee, S. -C., & Lobie, P. E.
(2019). Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma. Cancers, 11(10), 1528.
https://doi.org/10.3390/cancers11101528